Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

2.560

-0.050 (-1.92%)

At close: Apr 28, 2026, 4:00 PM EDT

2.670

+0.110 (4.30%)

After-hours: Apr 28, 2026, 4:57 PM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $10.85 million as of April 28, 2026. Its market cap has decreased by -13.85% in one year.

Market Cap

10.85M

Enterprise Value

-1.81M

1-Year Change

-13.85%

Ranking

#5158

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $10.85M, an increase of 44.73%. That is a compound annual growth rate of 1.82%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	11.10M	-11.20%
Dec 31, 2025	12.50M	1.63%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	9.86%
Dec 31, 2013	21.30M	-37.72%
Dec 31, 2012	34.20M	187.39%
Dec 30, 2011	11.90M	325.00%
Dec 31, 2010	2.80M	-98.80%
Dec 31, 2009	233.20M	2,164.08%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CDT Equity	12.10M
BioVie	11.99M
CytoMed Therapeutics	11.60M
Traws Pharma	11.58M
Reviva Pharmaceuticals Holdings	11.32M
Lunai Bioworks	11.19M
Chemomab Therapeutics	11.09M
Imunon	10.98M

Market Cap Rankings